Catalyst Wire Dossier Catalyst Wire Dossier

Eydenzelt

aflibercept · Celltrion Healthcare Hungary Kft.
Drug timelines are a Plus or Pro feature.

3 regulatory and trial events tracked for Eydenzelt, covering 2025-12-10 to 2026-07-01. Get the full timeline:

Most recent: EMA Authorised: Eydenzelt (aflibercept) — Celltrion Healthcare Hungary Kft.

See pricing